Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.

被引：2
|
作者：
Dieras, Veronique
Bachelot, Thomas
Campone, Mario
Isambert, Nicolas
Joly, Florence
Le Toumeau, Chrlstophe
Cassler, Philippe Alexandre
Bompas, Emmanuelle
Fumoloau, Pierre
Noal, Sabine
Orsini, Christina
Jimenez, Marta
Imbs, Diane Charlotte
Chatelut, Etienne
机构：
[1] Inst Curie, Paris, France
[2] Ctr Leon Berard, F-69373 Lyon, France
[3] Inst Cancerol Ouest, Nantes, France
[4] Ctr Georges Francois Leclerc, Dijon, France
[5] Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France
[6] Inst Curie, Dept Med Oncol, Paris, France
[7] Inst Cancerol Ouest, Dept Med Oncol, Nantes, France
[8] Ctr Francois Baclesse, F-14021 Caen, France
[9] UNICANCER, Paris, France
[10] Inst Claudius Regaud, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2583
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
    Yannis Metaxas
    Carmen Kahatt
    Vicente Alfaro
    Salvador Fudio
    Ali Zeaiter
    Ruth Plummer
    Cristiana Sessa
    Roger Von Moos
    Martin Forster
    Anastasios Stathis
    Investigational New Drugs, 2022, 40 : 91 - 98
  • [32] Phase I study of sorafenib, pemetrexed, and cisplatin for the treatment of advanced solid tumors
    Fujioka, N.
    Dudek, A.
    Kirstein, M. N.
    Kumar, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Final results of a phase I and pharmacokinetic (PK) study of OSI-7904L in combination with cisplatin (CDDP) in patients (pts) with advanced solid tumors.
    Ricart, AD
    Berlin, JD
    Syed, S
    Papadopoulos, K
    Drolet, D
    Quaratino-Baker, C
    Horan, J
    Chick, J
    Vermeulen, W
    Tolcher, AW
    Rowinsky, EK
    Rothenberg, ML
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9004S - 9005S
  • [34] Pemetrexed combined with gemcitabine and cisplatin:: a phase I study in patients with locally advanced or metastatic solid tumors
    Graefe, T.
    Luebbing, C.
    Bolling, C.
    Yilmaz, E.
    Fleeth, J.
    Luedtke, F. E.
    Mueller-Hagen, S.
    Depenbrock, H.
    Ohnmacht, U.
    Hanauske, A.-R.
    EJC SUPPLEMENTS, 2005, 3 (02): : 432 - 432
  • [35] Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors
    Fakih, MG
    Creaven, PJ
    Ramnath, N
    Trump, D
    Javle, M
    Strychor, S
    Repinski, TV
    Zamboni, BA
    Schwarz, JK
    French, RA
    Zamboni, WC
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5942 - 5949
  • [36] A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
    Kendra, Kari L.
    Plummer, Ruth
    Salgia, Ravi
    O'Brien, Mary E. R.
    Paul, Elaine M.
    Suttle, A. Benjamin
    Compton, Natalie
    Xu, Chun-Fang
    Ottesen, Lone H.
    Villalona-Calero, Miguel A.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (02) : 461 - 469
  • [37] Phase I, open-label study of olaparib plus cisplatin in patients with advanced solid tumors
    Balmana, Judith
    Tung, Nadine M.
    Isakoff, Steven J.
    Grana, Begona
    Ryan, Paula D.
    Rafi, Rezvan
    Tracy, Michael
    Winer, Eric
    Baselga, Jose
    Garber, Judy Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
    Burris, Howard A., III
    Dowlati, Afshin
    Moss, Rebecca A.
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Spigel, David R.
    Levinson, Kelly T.
    Lindquist, Diana
    Gainer, Shelby D.
    Dar, Mohammed M.
    Suttle, A. Benjamin
    Ball, Howard A.
    Tan, Antoinette R.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) : 1820 - 1828
  • [39] Phase I study of camrelizumab in patients with advanced solid tumors
    Yuxiang Ma
    Jiaxin Cao
    Yang Zhang
    Qianwen Liu
    Wenfeng Fang
    Yunpeng Yang
    Yuanyuan Zhao
    Qing Yang
    Hongyun Zhao
    Li Zhang
    Signal Transduction and Targeted Therapy, 8
  • [40] Phase I study of camrelizumab in patients with advanced solid tumors
    Ma, Yuxiang
    Cao, Jiaxin
    Zhang, Yang
    Liu, Qianwen
    Fang, Wenfeng
    Yang, Yunpeng
    Zhao, Yuanyuan
    Yang, Qing
    Zhao, Hongyun
    Zhang, Li
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
12345